Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan S Jaffe

Showing results (61-70 of 590) with videos related to

Pageof 59
Sort By:
EJIFCC|September 30, 2016
High Sensitivity Cardiac Troponin Assays - How to Implement them SuccessfullyFrederick K Korley, Allan S Jaffe
Clinical Biochemistry|April 25, 2012
Biomarkers of vulnerable plaque: can better ways to quantitate Pregnancy-Associated Plasma Protein A (PAPP-A) help?Amy K Saenger, Allan S Jaffe
Journal of the American College of Cardiology|June 2, 2012
Evaluation of patients with possible cardiac chest pain: a way out of the jungleErik P Hess, Allan S Jaffe
American Journal of Clinical Pathology|November 8, 2005
What is the IMA assay really saying?Fred S Apple, Allan S Jaffe
Clinical Chemistry|December 31, 2009
High-sensitivity cardiac troponin: hype, help, and realityAllan S Jaffe, Fred S Apple
Biomarkers in Medicine|May 19, 2010
New potential uses for cardiac troponinsVlad C Vasile, Allan S Jaffe
American Journal of Clinical Pathology|December 20, 2008
Refining our criteria: a critical challengeAllan S Jaffe, Fred S Apple
Circulation|November 19, 2008
Requiem for a heavyweight: the demise of creatine kinase-MBAmy K Saenger, Allan S Jaffe
Clinical Chemistry|January 18, 2013
The third Universal Definition of Myocardial Infarction--moving forwardAllan S Jaffe, Fred S Apple
Journal of the American College of Cardiology|February 12, 2013
Preparing the United States for high-sensitivity cardiac troponin assaysFrederick K Korley, Allan S Jaffe
Pageof 59

Showing results (61-70 of 590) with videos related to

Sort By:
Pageof 59
EJIFCC|September 30, 2016
High Sensitivity Cardiac Troponin Assays - How to Implement them SuccessfullyFrederick K Korley, Allan S Jaffe
Clinical Biochemistry|April 25, 2012
Biomarkers of vulnerable plaque: can better ways to quantitate Pregnancy-Associated Plasma Protein A (PAPP-A) help?Amy K Saenger, Allan S Jaffe
Journal of the American College of Cardiology|June 2, 2012
Evaluation of patients with possible cardiac chest pain: a way out of the jungleErik P Hess, Allan S Jaffe
American Journal of Clinical Pathology|November 8, 2005
What is the IMA assay really saying?Fred S Apple, Allan S Jaffe
Clinical Chemistry|December 31, 2009
High-sensitivity cardiac troponin: hype, help, and realityAllan S Jaffe, Fred S Apple
Biomarkers in Medicine|May 19, 2010
New potential uses for cardiac troponinsVlad C Vasile, Allan S Jaffe
American Journal of Clinical Pathology|December 20, 2008
Refining our criteria: a critical challengeAllan S Jaffe, Fred S Apple
Circulation|November 19, 2008
Requiem for a heavyweight: the demise of creatine kinase-MBAmy K Saenger, Allan S Jaffe
Clinical Chemistry|January 18, 2013
The third Universal Definition of Myocardial Infarction--moving forwardAllan S Jaffe, Fred S Apple
Journal of the American College of Cardiology|February 12, 2013
Preparing the United States for high-sensitivity cardiac troponin assaysFrederick K Korley, Allan S Jaffe
Pageof 59